formoline

Thinking Beyond GLP-1

Challenge and Strategic Objective

GLP-1 therapies have transformed the management of overweight and obesity. Yet for many patients, long-term treatment is limited by cost and tolerability concerns. This creates an opportunity for Formoline to establish itself as the ideal alternative and continuation strategy in the minds of physicians.

Idea

With its proven lipid-binding mechanism, favorable tolerability profile, and affordability, Formoline is a natural fit both before and after GLP-1 therapy. It can help delay the need for GLP-1 treatment or support patients transitioning off it, effectively extending the benefits achieved during therapy. The campaign captures this compelling promise in a simple but powerful way: With Formoline, prescribers can think beyond the injection.